273 related articles for article (PubMed ID: 3247626)
1. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
[No Abstract] [Full Text] [Related]
2. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
[No Abstract] [Full Text] [Related]
4. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
5. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
6. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
[No Abstract] [Full Text] [Related]
7. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
[No Abstract] [Full Text] [Related]
8. [Comparison of 2 chemotherapy protocols in adult acute myeloblastic leukemia. Results of the Instituto Nacional de la Nutrición Salvador Zubirán cooperative group].
Lobato-Mendizábal E; Ruiz-Argüelles GJ; Labardini-Méndez J; Gómez-Almaguer D; Ganci-Cerrud G; Lozano-de-la-Vega A
Rev Invest Clin; 1992; 44(1):63-9. PubMed ID: 1523351
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of acute nonlymphocytic leukemia induction chemotherapy in acute lymphocytic leukemia.
Cassileth PA; Bennett JM
Cancer Treat Rep; 1985 Dec; 69(12):1439-40. PubMed ID: 3865702
[TBL] [Abstract][Full Text] [Related]
10. [HOAP/HOAGP in the treatment of acute non-lymphocytic leukemia: an analysis of 68 cases].
Shan YD
Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):590-2. PubMed ID: 3938671
[No Abstract] [Full Text] [Related]
11. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
[No Abstract] [Full Text] [Related]
12. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and intensive treatment of acute leukemia in pregnancy].
Sierra J; Urbano Ispizua A; Cararach V; Carreras E; Fortuny A; Grañena A; Rozman C
Med Clin (Barc); 1987 Jan; 88(1):28-31. PubMed ID: 3469488
[No Abstract] [Full Text] [Related]
14. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
Vogler WR; Velez-Garcia E; Omura G; Raney M
Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
[No Abstract] [Full Text] [Related]
15. [Treatment of acute leukemias].
Gross R; Gerecke D
Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
[TBL] [Abstract][Full Text] [Related]
16. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
[No Abstract] [Full Text] [Related]
17. Aclacinomycin, cytosine arabinoside and thioguanine in relapsed or resistant acute myeloid leukemia.
Neri A; Comis M; Brugiatelli M; Martino B; Ronco F
Haematologica; 1989; 74(1):113-4. PubMed ID: 2498174
[No Abstract] [Full Text] [Related]
18. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia].
Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J
Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266
[No Abstract] [Full Text] [Related]
19. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923
[TBL] [Abstract][Full Text] [Related]
20. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
Creutzig U; Ritter I; Schellong G
Gematol Transfuziol; 1991 Jan; 36(1):16-21. PubMed ID: 2065939
[No Abstract] [Full Text] [Related]
[Next] [New Search]